Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

V-Akt Murine Thymoma Viral Oncogene Homolog 2 (AKT2) (Middle Region) Peptid

AKT2 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN973084
  • Target Alle AKT2 Produkte
    AKT2 (V-Akt Murine Thymoma Viral Oncogene Homolog 2 (AKT2))
    Protein Region
    Middle Region
    Spezies
    Human
    Quelle
    • 10
    Synthetic
    Applikation
    Blocking Peptide (BP), Western Blotting (WB)
    Produktmerkmale
    This is a synthetic peptide designed for use in combination with anti-AKT2 antibody (Catalog #: ARP30321_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Aufreinigung
    Purified
  • Applikationshinweise
    Each Investigator should determine their own optimal working dilution for specific applications.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Konzentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Handhabung
    Avoid repeated freeze-thaw cycles.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    AKT2 (V-Akt Murine Thymoma Viral Oncogene Homolog 2 (AKT2))
    Synonyme
    AKT2 Peptide, pkbb Peptide, pkbbeta Peptide, pkbss Peptide, prkbb Peptide, rac-beta Peptide, v-akt2 Peptide, 2410016A19Rik Peptide, AW554154 Peptide, PKB Peptide, PKBbeta Peptide, HIHGHH Peptide, PKBB Peptide, PKBBETA Peptide, PRKBB Peptide, RAC-BETA Peptide, cb945 Peptide, akt2-a Peptide, AKT serine/threonine kinase 2 Peptide, v-akt murine thymoma viral oncogene homolog 2 Peptide, thymoma viral proto-oncogene 2 Peptide, v-akt murine thymoma viral oncogene homolog 2 L homeolog Peptide, AKT2 Peptide, akt2 Peptide, Akt2 Peptide, akt2.L Peptide
    Hintergrund
    AKT2 belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains. The gene encoding AKT2 was shown to be amplified and overexpressed in 2 of 8 ovarian carcinoma cell lines and 2 of 15 primary ovarian tumors. Overexpression contributes to the malignant phenotype of a subset of human ductal pancreatic cancers. AKT2 is a general protein kinase capable of phophorylating several known proteins.This gene is a putative oncogene encoding a protein belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains. The gene was shown to be amplified and overexpressed in 2 of 8 ovarian carcinoma cell lines and 2 of 15 primary ovarian tumors. Overexpression contributes to the malignant phenotype of a subset of human ductal pancreatic cancers. The encoded protein is a general protein kinase capable of phophorylating several known proteins. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.

    Alias Symbols: PKBBETA, PRKBB, RAC-BETA, PKBB, HIHGHH

    Protein Interaction Partner: APPL1,CHUK,TCL1A,AKT1,AKT1S1,AKT2,APPL1,CHUK,ESR1,FOXO4,FSHR,GSK3B,HSP90AA1,MTCP1,PDPK1,RAB3D,SH3RF1,SLC2A4,TCL1A,TCL1B,TRIB3,TSC2,XIAP,APPL1,CHUK,GSK3B,MTCP1,PRKDC,SH3RF1,TCL1A,TCL1B

    Protein Size: 481
    Molekulargewicht
    56 kDa
    Gen-ID
    208
    NCBI Accession
    NM_001626, NP_001617
    UniProt
    P31751
Sie sind hier:
Kundenservice